Investment
Features
FeesSafety
Academy
More
Pluang+

Compare JetBlue Airways Corporation (JBLU) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

JetBlue Airways CorporationTrade
Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

JetBlue Airways Corporation vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? JetBlue Airways Corporation trades at $3.02 (market cap $1.26B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 8.6× JetBlue Airways Corporation's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while JetBlue Airways Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold JetBlue Airways Corporation for 44 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

JBLURDY
Market Cap
$1.26B$10.78B
Volume
40,642,5252,724,343
Sector
IndustrialsHealth
52-Week High
$6.46$15.38
52-Week Low
$3.01$11.38
Typical Hold Time
44 Days0 Days
Enterprise Value
$8.63B$10.68B
Dividend Yield
—0.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

JetBlue Airways Corporation

JetBlue (JBLU) trades at $3.01, down 16.85% in the last 24 hours, reflecting significant bearish pressure. The stock exhibits weak fundamentals with a negative net income margin of -9.32% and consecutive quarterly losses, though it beat EPS expectations in Q2 2026. Technical indicators are predominantly bearish, with the stock trading near key support levels. Recent news highlights expansion efforts like new routes to Colombia and the launch of BlueFirst premium seating, aiming to boost revenue amid industry challenges.

The outlook remains challenging due to persistent losses, high debt levels, and elevated fuel costs. While analyst consensus suggests a hold rating with a $5.89 price target implying potential upside, risks from competitive pressures and macroeconomic factors dominate. Investment appeal is limited to speculative positions betting on a operational turnaround despite current headwinds.

Dr. Reddy's Laboratories Ltd Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JBLU
91% Buy9% Sell
Avg holding period · 44 Days
RDY
100% Buy0% Sell
Avg holding period · 0 Days

About JetBlue Airways Corporation

JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.

Read more on JBLU →

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →